ArticleBlood advances2022

Transplant outcomes after CPX-351 vs 7 + 3 in older adults with newly diagnosed high-risk and/or secondary AML.

Geoffrey L Uy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.